Latest News about GSK
Recent news which mentions GSK
GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine
April 27, 2022
Tickers
GSK
From Benzinga
From Benzinga
From MarketWatch
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
April 22, 2022
From Benzinga
From Benzinga
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
April 17, 2022
From Benzinga
From Motley Fool
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
Why Is Sierra Oncology (SRRA) Stock Up Today?
April 13, 2022
From InvestorPlace
Sierra Oncology Stock Is Soaring: Here's Why
April 13, 2022
From Benzinga
From Benzinga
Why Sierra Oncology Stock Is Soaring Today
April 13, 2022
From Motley Fool
From Benzinga
From InvestorPlace
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
April 13, 2022
From MarketWatch
From Benzinga
This Exciting Biotech Stock Could Be Your Next 10-Bagger
April 10, 2022
From Motley Fool
3 Pharmaceutical Stocks With Awesome Futures
April 09, 2022
From Motley Fool
3 Things About Pfizer That Smart Investors Know
April 08, 2022
From Motley Fool
From Benzinga
From Benzinga
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
Why Shares of Vir Biotechnology Rose 20.4% This Week
April 01, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.